Never Too Late?
Fragile X Can Be Reversed by Glutamate Receptor Blocker
By treating mice with an inhibitor of one type of glutamate receptor, scientists from Roche AG have been able to reverse most symptoms of Fragile X disease in young adult animals. The findings add to the evidence that Fragile X, like a number of other neurodevelopmental disorders, remains treatable even after symptoms have developed.
